newsfilter
← Latest News
Business Wire·

LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

– Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced new